Your browser doesn't support javascript.
loading
STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.
Sachdev, Perminder S; Lo, Jessica W; Crawford, John D; Mellon, Lisa; Hickey, Anne; Williams, David; Bordet, Régis; Mendyk, Anne-Marie; Gelé, Patrick; Deplanque, Dominique; Bae, Hee-Joon; Lim, Jae-Sung; Brodtmann, Amy; Werden, Emilio; Cumming, Toby; Köhler, Sebastian; Verhey, Frans R J; Dong, Yan-Hong; Tan, Hui Hui; Chen, Christopher; Xin, Xu; Kalaria, Raj N; Allan, Louise M; Akinyemi, Rufus O; Ogunniyi, Adesola; Klimkowicz-Mrowiec, Aleksandra; Dichgans, Martin; Wollenweber, Frank A; Zietemann, Vera; Hoffmann, Michael; Desmond, David W; Linden, Thomas; Blomstrand, Christian; Fagerberg, Björn; Skoog, Ingmar; Godefroy, Olivier; Barbay, Mélanie; Roussel, Martine; Lee, Byung-Chul; Yu, Kyung-Ho; Wardlaw, Joanna; Makin, Stephen J; Doubal, Fergus N; Chappell, Francesca M; Srikanth, Velandai K; Thrift, Amanda G; Donnan, Geoffrey A; Kandiah, Nagaendran; Chander, Russell J; Lin, Xuling.
Afiliação
  • Sachdev PS; Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia.
  • Lo JW; Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
  • Crawford JD; Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
  • Mellon L; Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Hickey A; Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Williams D; Department of Stroke and Geriatric Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Bordet R; University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
  • Mendyk AM; University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
  • Gelé P; University of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
  • Deplanque D; University of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
  • Bae HJ; Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Lim JS; Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Brodtmann A; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
  • Werden E; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
  • Cumming T; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
  • Köhler S; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Verhey FR; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Dong YH; Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Depar
  • Tan HH; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, Na
  • Chen C; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Xin X; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Kalaria RN; Neurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • Allan LM; Neurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • Akinyemi RO; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Ogunniyi A; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Klimkowicz-Mrowiec A; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Dichgans M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Wollenweber FA; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
  • Zietemann V; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
  • Hoffmann M; Cognitive Neurology and Stroke Programs, University of Central Florida, Orlando VA Medical Center, Orlando, Florida, USA.
  • Desmond DW; No Affiliation.
  • Linden T; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia; Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Hunter Medical Research Institute, Newcastle,
  • Blomstrand C; Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Fagerberg B; Department of Molecular and Clinical Medicine, Wallenberg Laboratory for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Skoog I; Institute of Neuroscience and Physiology, Center for Health and Ageing AGECAP, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Godefroy O; Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
  • Barbay M; Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
  • Roussel M; Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
  • Lee BC; Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Yu KH; Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Wardlaw J; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Makin SJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
  • Doubal FN; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Chappell FM; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Srikanth VK; Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
  • Thrift AG; Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea; Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia.
  • Donnan GA; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
  • Kandiah N; Department of Neurology, National Neuroscience Institute, Singapore.
  • Chander RJ; Department of Neurology, National Neuroscience Institute, Singapore.
  • Lin X; Department of Neurology, National Neuroscience Institute, Singapore.
Alzheimers Dement (Amst) ; 7: 11-23, 2017.
Article em En | MEDLINE | ID: mdl-28138511
ABSTRACT

INTRODUCTION:

The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).

METHODS:

Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.

RESULTS:

Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years.

DISCUSSION:

Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália